State Serum Institute expects COVID-19 cases to rise 

According to a new SSI prognosis, the coronavirus situation in Denmark is set to gather momentum over the next 14 days

Just a week ago, the State Serum Institute (SSI) announced that it expected the number of COVID-19 cases to dwindle in the near future.

But today, the health experts had a very different opinion.

Over the next fortnight or so, the number of new coronavirus cases in Denmark is expected to increase nationwide, according to a new SSI prediction.

READ ALSO: University of Copenhagen behind promising COVID-19 vaccine

Up to 1,350 … maybe
Using a mathematical model, the prognosis suggests the number of new cases will go up to about 1,350 on a daily basis by the beginning of December.

That figure depends on about 51,000 tests being taken every day.

Currently, the number of cases being registered daily is at about 1,100-1,200.

SSI underlined that its prognosis, which is updated every Tuesday, is subject to various uncertainties. 





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.